A15 Holdings

A15 Holdings is a Cairo-based entrepreneurial investment company empowering digital tech brands from idea stage through Series A in the MENA region. Check sizes of $250k to $1M place the firm in the seed range. Healthcare exposure includes digital health and health-IT software, with explicit AI thematic positioning. The firm operates with a builder-investor mindset, often involved operationally with portfolio companies.

The firm’s natural fit is with very early-stage MENA founders building digital tech brands in fragmented industries, including healthcare. For healthcare founders specifically, the right profile is a team building digital health platforms, health-IT software, or AI-enabled clinical or operational tools with credible MENA commercial wedge. Founders willing to engage with the firm’s operational involvement (product, GTM, regional expansion) will find the model more useful than founders preferring arms-length capital. Founders building deep biotech, pure US-market software, or anything requiring extensive patient capital are not the natural target.

Geographically, A15’s advantage is its position in Cairo, MENA’s largest population market, and its long track record in Egyptian and broader MENA tech. The firm has connectivity to regional follow-on capital from GCC-affiliated funds. For MENA-anchored founders, the firm is a credible early partner. For non-MENA founders, the strategic logic is thin.

The right entry path is a warm intro from a portfolio founder or a regional MENA VC. The firm reads partner-led decks and responds to clear theses with MENA market relevance. The pitch should lead with the regional commercial wedge, evidence of early traction or strong technical depth, founder team credibility, and a credible follow-on plan. AI narrative should connect to specific outcomes.

Caveats. Egyptian fund structures interact with cross-border venture dynamics in idiosyncratic ways, including Egyptian pound and FX considerations; engage experienced regional counsel. The firm’s healthcare-specific portfolio depth is not as visible publicly as its broader digital tech portfolio; reference calls with portfolio founders are advisable. The check size is moderate; for founders raising larger seeds, A15 should be a participant alongside a real lead. For MENA-anchored health-tech founders willing to engage with operational involvement, A15 Holdings is a thoughtful early partner; for founders preferring arms-length capital or without MENA ties, the fit is weaker.